Skip to main content

Year: 2026

Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers HOUSTON, April 28, 2026 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today a new payer coverage agreement with Blue Shield of California, effective April 2026, providing reimbursement for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) assay for patients with metastatic central nervous system cancers. Blue Shield of California joins a growing list of national and regional payers, including United Healthcare, Humana, and Highmark, that provide coverage for CNSide. The addition of Blue Shield of California expands CNSide’s total covered lives from approximately 75 million to 81 million, representing continued...

Continue reading

Watsco First Quarter Performance Reflects Stabilizing Markets, Improved Operating Efficiency and Expanded Technology Adoption

Company to Acquire Jackson Supply Company, Leading Sunbelt Distributor with Annual Sales of $230 Million MIAMI, April 28, 2026 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) today announced its operating results for the first quarter ended March 31, 2026. Watsco also announced that it has entered into an agreement to acquire Jackson Supply Company, one of the largest Sunbelt HVAC distributors, with annual sales of $230 million. The transaction is expected to close in the second quarter of 2026, pending completion of customary closing conditions. Following closing, Jackson Supply will continue to be led by its existing management team, in keeping with Watsco’s long-standing approach of investing in great leaders and successful cultures. Watsco is the largest distributor in the highly fragmented North American HVAC market. Since...

Continue reading

Watsco To Acquire Jackson Supply Company

$230 Million Distributor Adds 25 Locations in Core Sunbelt Markets Buy-and-Build Opportunity Adds Scale and Leverages Long-Term Technology Advantage MIAMI, April 28, 2026 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today the signing of a definitive agreement to acquire Jackson Supply Company. Founded in 1972, Jackson Supply Company is one of the Sunbelt’s largest HVAC distributors with sales of $230 million in 2025. The Company serves approximately 5,000 customers from 25 locations in high-growth Sunbelt markets such as Texas, Louisiana, Tennessee, Alabama, Mississippi, Oklahoma and Arizona. Its diversified, balanced product offering includes Goodman and Amana brand HVAC equipment manufactured by Daikin Comfort Technologies North America, Inc. along with a broad array of supplies, accessories, and parts sourced from approximately...

Continue reading

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net product revenue increased to $930 – $945 million –– KPL-387 Phase 2 recurrent pericarditis data expected in 2H 2026; Phase 3 pivotal trial expected to initiate by year-end –– Q1 2026 cash balance increased to $468.1 million – – Conference call and webcast scheduled for 8:30 am ET today – LONDON, April 28, 2026 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications, today reported first quarter 2026 financial results and recent portfolio execution. “Five years from launch, Kiniksa continues to deliver strong...

Continue reading

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the trial remains on track to initiate in 2Q 2026 Combination and maintenance trials of WVE-007 on track to initiate in 2026 Data from RestorAATion-2 trial of WVE-006 (GalNAc-RNA editing) in AATD (including 400 mg monthly dose and 600 mg single dose cohorts) to be presented at an investor webcast during the ATS International Conference in May 2026 Regulatory feedback on accelerated approval pathway for WVE-006 continues to be expected mid-2026 CTA submission for WVE-008 (GalNAc-RNA editing for PNPLA3 I148M liver disease) on track for 2026 Well capitalized with cash and cash equivalents of $544.6 million as of March 31, 2026 and expected cash runway...

Continue reading

Schouw & Co. share buy-back programme, week 17 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 17 April 2026 113,283 668.21 75,697,216    Monday, 20 April 2026 1,000 662.23 662,232    Tuesday, 21 April 2026 1,000 662.60 662,600    Wednesday, 22 April 2026 1,000 656.00 656,000    Thursday, 23 April 2026 1,000 645.00 645,000    Friday,...

Continue reading

Exodus Movement Appoints Receiver in United Kingdom to Take Control of Monavate and Baanx

OMAHA, Neb., April 28, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced that it has exercised its contractual right to appoint Receivers in the United Kingdom to take control of Monavate Holdings Limited, Monavate Ltd and Baanx.com Ltd — three subsidiaries of W3C Corp (“W3C”), whose shares were pledged as security for a secured loan on which W3C has defaulted.   Exodus is a secured lender to W3C, having loaned $70 million to W3C under a term facility governed by English law. As previously disclosed, on April 13, 2026, Exodus declared these loans to be payable on demand. On April 27, 2026, Exodus demanded immediate repayment of its on-demand loan by 5:00 p.m. BST. When W3C failed to repay the loan, Exodus exercised its contractual...

Continue reading

Jiayin Group Inc. Filed Annual Report on Form 20-F for Fiscal Year 2025

SHANGHAI, April 28, 2026 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it has filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”) on April 28, 2026, U.S. Eastern Time. The Annual Report can be accessed on the Company’s investor relations website at https://ir.jiayintech.cn/ and on the SEC’s website at https://www.sec.gov/. The Company will provide a hard copy of its Annual Report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at ir@jiayinfintech.cn. About...

Continue reading

Microchip Expands its Family of Post-Quantum‑Ready Root of Trust Controllers for Next‑Generation Systems

Platform Root of Trust and secure boot controllers help system architects prepare for emerging mandates across data center and infrastructure platforms CHANDLER, Ariz., April 28, 2026 (GLOBE NEWSWIRE) — CHANDLER, Ariz., April 28, 2026 — As the industry embarks on the transition to post‑quantum cryptography (PQC), Microchip Technology (Nasdaq: MCHP) is expanding its portfolio of Trust Shield, PQC‑ready devices with the TS1800 Platform Root of Trust controller and the TS50x secure boot controller. The devices are designed to help system architects address emerging cybersecurity mandates, including the European Cyber Resilience Act (CRA) and Commercial National Security Algorithm Suite 2.0 (CNSA 2.0), while supporting evolving data center, compute, defense, telecommunication and infrastructure security standards. The TS1800 integrated...

Continue reading

Sportradar Appoints Sameer Deen as Chief Operating Officer

Seasoned Industry Leader Brings Extensive Sports Betting and Digital Experience to Drive the Company’s Next Phase of Growth and Strategic Innovation ST. GALLEN, Switzerland, April 28, 2026 (GLOBE NEWSWIRE) — Sportradar Group AG (Nasdaq: SRAD)(“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced that gaming and digital industry executive Sameer Deen has been named Chief Operating Officer (COO) of the Company, effective May 18, 2026. He will report directly to Sportradar’s Chief Executive Officer, Carsten Koerl. In his role as COO, Mr. Deen will oversee Commercial and Group Operations while collaborating closely with the executive leadership team to advance the organization’s strategy and growth. With a unique blend of strategic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.